Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Ezfil

K-Number: K191991 · 2020-03-05

Decision Date2020-03-05
Product CodeEBF
Advisory CommitteeDE
DecisionSubstantially Equivalent

Device Summary

Ezfil is the device name listed in this FDA 510(k) record. The listed applicant is Meta Biomed Co., Ltd.. It received FDA 510(k) clearance on 2020-03-05 under 510(k) number K191991. The device is classified under product code EBF. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Ezfil?

Ezfil is a medical device that received FDA 510(k) clearance on 2020-03-05. The listed applicant is Meta Biomed Co., Ltd.. The 510(k) number is K191991.

When did Ezfil receive FDA 510(k) clearance?

Ezfil received FDA 510(k) clearance on 2020-03-05, under 510(k) number K191991.

Who is the listed applicant for Ezfil?

The FDA 510(k) record lists Meta Biomed Co., Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Ezfil?

The FDA product code for Ezfil is EBF.

Other records listing Meta Biomed Co., Ltd. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 13 devices →

Related Devices (Code: EBF)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.